… 6–12 months after acute COVID-19. Particularly, we focused on the prevalence of abnormalities
demonstrated by objective tools of pulmonary assessment, including PFT and chest CT. …

… the prevalence of pulmonary abnormalities 90 days after COVID-19 symptom onset and …
an automated method of quantifying pulmonary sequelae in post-acute COVID-19 patients. …

… Our findings confirm that cognitive abnormalities can detect 12 months after patients have
COVID-19 and in many cases (42.8% in our sample) these are associated with abnormal brain …

… COVID-19 were reported worldwide [4]. The most common diagnostic tool for coronavirus
disease 2019 (COVID-19) … Magnitude of abnormal chest CT finding of patients with COVID-19. …

… compared with chest CT in the detection of lung abnormalities in COVID-19 patients. … LUS
had accuracy similar to that of chest CT in detecting lung abnormalities in COVID-19 patients. …

… Dual energy CT may be useful for the evaluation of lung perfusion abnormalities in COVID-19
patients not only in the acute setting 81 but also to monitor lung sequelae in follow-up …

… abnormalities at chest CT in children with proven COVID-19. … confirmed COVID-19 infection
had no sign of abnormality at … but very modest radiologic abnormality before treatment in the …

… chest computed tomography features in coronavirus disease 2019 (COVID-19) pneumonia
associated to the novel coronavirus, severe acute respiratory syndrome coronavirus 19. The …

… COVID-19 and demonstrated that more than half of the recovered patients still had chest
computed tomography (CT) abnormalities … abnormalities in recovered patients from COVID-19. …

… At present, confirmation of COVID-19 infection mainly depends on detection through …
resolution computed tomography (HRCT) is an important method for detecting lung abnormalities. It …